Third, although clinical trial studies with Ang II inhibitors and angiotensin receptor blockers indicates the critical roles of ACE2 COVID-19 pathogenesis, there remains a pressing need to develop effective therapeutic strategies through clinical trials and studies in animal models. Here, AGT is linked to COVID-19.